Main navigation
|
 |
| |
HIV/AIDS |
Main content
|
Antiretroviral therapy
|
Standard antiretroviral therapy (ART) consists of the use of at least three antiretroviral (ARV) drugs to maximally suppress the HIV virus and stop the progression of HIV disease. Huge reductions have been seen in rates of death and suffering when use is made of a potent ARV regimen.
About 33 million people are now living with HIV, of whom more than 30 million live in low- and middle-income countries. WHO estimates that at least 9.7 million of these people are in need of ART. As of the end of 2008, 4 million people had access to ART in low- and middle-income countries.
WHO is providing countries with ongoing guidance, tools and support in delivering and scaling up ART within a public health approach.
|
Latest updates
ART guideline revisions
WHO is currently revising the ART and ART to prevent mother-to-child transmission of HIV guidelines, and has released information on the revision process, including timelines, areas for review, relevant outcomes, and ideal recommendations.
ART guidelines revision process
|
MTCT guidelines revision process
Important: addendum to 2006 ART guidelines
Important: addendum to 2006 WHO guidelines on "Antiretroviral therapy for HIV infection in adults and adolescents". New dosage recommendations for Stavudine (d4T).
Download the addendum (English) [pdf 107kb]
|
(French) [pdf 28kb]
Antiretroviral therapy for HIV infection in adults and adolescents
WHO released a revised version of the guidelines on "Antiretroviral therapy for HIV infection in adults and adolescents" in August 2006.
Access the guidelines
|
|
|
|
|
|
